Medical instrument manufacturer ZimVie (ZIMV) Thursday said it has furthered cooperation with diversified spine imaging firm Brainlab and started a project to make their systems…

ZimVie and Brainlab will cooperate on achieving compatibility between ZimVie''s Vital and Virage® fixation systems with the Brainlab spine and trauma technologies for global co-marketing purposes W…

ZimVie and Brainlab will cooperate on achieving compatibility between ZimVie’s Vital™ and Virage ® fixation systems with the Brainlab spine and trauma technologies for global co-marketing purposes

ZimVie (ZIMV) traded higher pre-market Thursday after announcing that the FDA approved a smaller height of its Mobi-C cervical disc implant. Read more here.

https://www.investing.com/news/assorted/zimvie-inc-announces-fda-approval-for-new-mobic-implant-432SI-3151207

Smaller height implants in all Mobi-C footprints to address patient anatomy WESTMINSTER, Colo., Aug. 10, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that on August 1st, 2023, the U.S. Food and Drug Administration approved a smaller height of the Mobi-C Cervical Disc in seven footprints that will address the

The following slide deck was published by ZimVie Inc.

https://www.investing.com/news/pro/zimvie-receives-investment-bank-analyst-rating-update-3147597

ZimVie Inc. (NASDAQ:NASDAQ:ZIMV) Q2 2023 Earnings Conference Call August 2, 2023 4:30 PM ETCompany ParticipantsMarissa Bych - Investor Relations, Gilmartin Group LLCVafa Jamali - President…